Bank of New York Mellon’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,576
| Closed | -$4.19K | – | 4420 |
|
|
2022
Q4 | $4.19K | Hold |
1,576
| – | – | ﹤0.01% | 4450 |
|
|
2022
Q3 | $6K | Hold |
1,576
| – | – | ﹤0.01% | 4525 |
|
|
2022
Q2 | $5K | Hold |
1,576
| – | – | ﹤0.01% | 4572 |
|
|
2022
Q1 | $7K | Hold |
1,576
| – | – | ﹤0.01% | 4647 |
|
|
2021
Q4 | $15K | Hold |
1,576
| – | – | ﹤0.01% | 4599 |
|
|
2021
Q3 | $27K | Hold |
1,576
| – | – | ﹤0.01% | 4484 |
|
|
2021
Q2 | $44K | Sell |
1,576
-6,218
| -80% | -$174K | ﹤0.01% | 4332 |
|
|
2021
Q1 | $174K | Sell |
7,794
-1,694
| -18% | -$37.8K | ﹤0.01% | 4087 |
|
|
2020
Q4 | $137K | Sell |
9,488
-211
| -2% | -$3.05K | ﹤0.01% | 4039 |
|
|
2020
Q3 | $145K | Hold |
9,699
| – | – | ﹤0.01% | 3912 |
|
|
2020
Q2 | $201K | Buy |
9,699
+1,432
| +17% | +$29.7K | ﹤0.01% | 3795 |
|
|
2020
Q1 | $157K | Hold |
8,267
| – | – | ﹤0.01% | 3794 |
|
|
2019
Q4 | $238K | Sell |
8,267
-51
| -0.6% | -$1.47K | ﹤0.01% | 3866 |
|
|
2019
Q3 | $424K | Buy |
8,318
+134
| +2% | +$6.83K | ﹤0.01% | 3625 |
|
|
2019
Q2 | $648K | Buy |
8,184
+5,746
| +236% | +$455K | ﹤0.01% | 3476 |
|
|
2019
Q1 | $161K | Sell |
2,438
-249
| -9% | -$16.4K | ﹤0.01% | 3917 |
|
|
2018
Q4 | $149K | Buy |
+2,687
| New | +$149K | ﹤0.01% | 3899 |
|